Documents
Application Sponsors
| ANDA 206674 | INVAGEN PHARMS |  | 
Marketing Status
| Prescription | 001 | 
| Prescription | 002 | 
| Prescription | 003 | 
Application Products
| 001 | TABLET, EXTENDED RELEASE;ORAL | 100MG | 0 | BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | 
| 002 | TABLET, EXTENDED RELEASE;ORAL | 150MG | 0 | BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | 
| 003 | TABLET, EXTENDED RELEASE;ORAL | 200MG | 0 | BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | 
FDA Submissions
| UNKNOWN;  | ORIG | 1 | AP | 2016-02-09 | STANDARD  | 
| LABELING; Labeling | SUPPL | 5 | AP | 2021-01-04 | STANDARD  | 
| LABELING; Labeling | SUPPL | 10 | AP | 2021-01-04 | STANDARD  | 
| LABELING; Labeling | SUPPL | 13 | AP | 2021-01-04 | STANDARD  | 
Submissions Property Types
| ORIG | 1 | Null | 7 | 
| SUPPL | 5 | Null | 7 | 
| SUPPL | 10 | Null | 7 | 
| SUPPL | 13 | Null | 15 | 
TE Codes
| 001 | Prescription | AB1 | 
| 002 | Prescription | AB1 | 
| 003 | Prescription | AB1 | 
CDER Filings
INVAGEN PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206674
            [companyName] => INVAGEN PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"BUPROPION HYDROCHLORIDE","activeIngredients":"BUPROPION HYDROCHLORIDE","strength":"100MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"BUPROPION HYDROCHLORIDE","activeIngredients":"BUPROPION HYDROCHLORIDE","strength":"150MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"BUPROPION HYDROCHLORIDE","activeIngredients":"BUPROPION HYDROCHLORIDE","strength":"200MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"02\/09\/2016","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2016\\\/206674Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"01\/04\/2021","submission":"SUPPL-13","supplementCategories":"Labeling-Medication Guide, Labeling-Patient Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"01\/04\/2021","submission":"SUPPL-10","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"01\/04\/2021","submission":"SUPPL-5","supplementCategories":"Labeling-Package Insert, Labeling-Medication Guide","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"04\/17\/2017","submission":"SUPPL-1","supplementCategories":"Labeling-Medication Guide, Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2021-01-04
        )
)